THC
60
-4
SJM
14
-2
STT
67
2
BDX
61
2
HOG
45
3
ADBE
44
3
SE
47
-5
HIG
56
-7
BXP
46
-3
MOS
26
-3
MMC
60
2
HCA
66
-5
COF
65
2
PSA
56
5
NEE
75
4
CFG
89
4
MO
54
-3
VMC
59
3
CTAS
33
3
NSC
64
2
THC
60
-4
SJM
14
-2
STT
67
2
BDX
61
2
HOG
45
3
ADBE
44
3
SE
47
-5
HIG
56
-7
BXP
46
-3
MOS
26
-3
MMC
60
2
HCA
66
-5
COF
65
2
PSA
56
5
NEE
75
4
CFG
89
4
MO
54
-3
VMC
59
3
CTAS
33
3
NSC
64
2
Financhill
Back

AXIM Biotechnologies, Inc. 10K Form

Buy
53

AXIM
AXIM Biotechnologies, Inc.

Last Price:
$0.0200
Seasonality Move:
5.9%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive AXIM News And Ratings

See the #1 stock for the next 7 days that we like better than AXIM

AXIM Financial Statistics

Sales & Book Value

Annual Sales: $70.5K
Cash Flow: $-133.1K
Price / Cash Flow: 0
Annual Sales: $-0.03
Price / Book: 0

Profitability

EPS (TTM): -0.02480
Net Income (TTM): $-4.7M
Gross Margin: $-369.3K
Return on Equity: 0%
Return on Assets: -103.02%

AXIM Biotechnologies, Inc. Earnings Forecast

Key AXIM Biotechnologies, Inc. Financial Ratios

  • The Gross Profit Margin over the past 14 years for AXIM is -523.83%.
  • The Selling, General & Administrative Expenses for AXIM have been equal to 1,920.57% of Gross Profit Margin.
  • The Research & Development expenses have been 56.45% of Revenue.
  • The Net Earning history of AXIM is -4,982.27% of Total Revenues.
  • Per Share Earnings over the last 14 years have been positive in 7 years.

AXIM Biotechnologies, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Biotechnology
Sector: Health Care
Current Symbol: AXIM
Website: aximbiotech.com

Debt

Debt-to-Equity Ratio: -0.69
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

AXIM Technical Analysis vs Fundamental Analysis

Buy
53
AXIM Biotechnologies, Inc. (AXIM) is a Buy

Is AXIM Biotechnologies, Inc. a Buy or a Sell?